{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:11:13Z","timestamp":1761581473447,"version":"3.41.0"},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,10]]},"DOI":"10.18632\/oncotarget.12239","type":"journal-article","created":{"date-parts":[[2016,9,25]],"date-time":"2016-09-25T03:32:45Z","timestamp":1474774365000},"page":"3568-3580","source":"Crossref","is-referenced-by-count":17,"title":["Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis"],"prefix":"10.18632","volume":"8","author":[{"given":"Xiao","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaheng","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongquan","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidong","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengdi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyuan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengchao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiwei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,24]]},"reference":[{"issue":"1","key":"1","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Jemal","year":"2012","journal-title":"CA: a cancer journal for clinicians"},{"issue":"2","key":"2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11934-013-0305-1","article-title":"Conservative nephron-sparing treatment of upper-tract tumors","volume":"14","author":"Raman","year":"2013","journal-title":"Current urology reports"},{"issue":"2","key":"3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.hoc.2014.10.003","article-title":"Diagnosis and Management of Upper Tract Urothelial Carcinoma","volume":"29","author":"Chang","year":"2015","journal-title":"Hematology\/oncology clinics of North America"},{"issue":"6","key":"4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Wood","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3349\/ymj.2015.56.2.375","article-title":"The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision","volume":"56","author":"Ku","year":"2015","journal-title":"Yonsei medical journal"},{"issue":"1","key":"6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2013.08.033","article-title":"Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials","volume":"66","author":"Bellmunt","year":"2014","journal-title":"European urology"},{"issue":"12","key":"7","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma","volume":"120","author":"Matin","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.suronc.2009.10.001","article-title":"Treatment of upper urinary tract urothelial carcinoma","volume":"20","author":"Wu","year":"2011","journal-title":"Surgical oncology"},{"issue":"11","key":"9","first-page":"940","article-title":"Value of postoperative radiotherapy in malignant tumors of the upper urinary tract. Apropos of a series of 26 patients","volume":"83","author":"Housset","year":"1996","journal-title":"Bulletin du cancer"},{"issue":"1","key":"10","first-page":"333","article-title":"Adjuvant radiotherapy for stage III\/IV urothelial carcinoma of the upper tract","volume":"34","author":"S","year":"2014","journal-title":"Anticancer research"},{"key":"11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2407-11-297","article-title":"Radiotherapy may improve overall survival of patients with T3\/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse","volume":"11","author":"Ji","year":"2011","journal-title":"BMC cancer"},{"issue":"4","key":"12","first-page":"1271","article-title":"Adjuvant Radiotherapy with and without Concurrent Chemotherapy for Locally Advanced Transitional Cell Carcinoma of the Renal Pelvis and Ureter","volume":"172","author":"Shipley","year":"2004","journal-title":"The Journal of urology"},{"issue":"1","key":"13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.juro.2009.08.154","article-title":"Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?","volume":"183","author":"Huang","year":"2010","journal-title":"The Journal of urology"},{"issue":"4","key":"14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)","volume":"60","author":"British Association of Urological Surgeons Section of","year":"2011","journal-title":"European urology"},{"issue":"11","key":"15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jjco\/hyt129","article-title":"Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial","volume":"43","author":"Yamashita","year":"2013","journal-title":"Japanese journal of clinical oncology"},{"issue":"12","key":"16","first-page":"4734","article-title":"Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract","volume":"7","author":"Yin","year":"2014","journal-title":"International journal of clinical and experimental medicine"},{"key":"17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Sydes","year":"2007","journal-title":"Trials"},{"issue":"4","key":"18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General Methods for Monitoring Convergence of Iterative Simulations","volume":"7","author":"Gelman","year":"1998","journal-title":"Journal of Computational and Graphical Statistics"},{"key":"19","unstructured":"Wells GA, O\u2019Connell, Peterson\u2019Connell, Welch, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013."},{"issue":"1","key":"20","first-page":"e17","article-title":"Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome","volume":"32","author":"Bell","year":"2014","journal-title":"Urologic oncology"},{"issue":"1","key":"21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4111\/kju.2015.56.1.41","article-title":"Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy","volume":"56","author":"Han","year":"2015","journal-title":"Korean journal of urology"},{"issue":"2","key":"22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.juro.2015.03.077","article-title":"The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma","volume":"194","author":"Wu","year":"2015","journal-title":"The Journal of urology"},{"issue":"1","key":"23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1097-0142(19940701)74:1<123::AID-CNCR2820740121>3.0.CO;2-T","article-title":"Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract","volume":"74","author":"von der Maase","year":"1994","journal-title":"Cancer"},{"key":"24","article-title":"European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update","author":"Shariat","year":"2015","journal-title":"European urology"},{"issue":"4","key":"25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eururo.2013.11.046","article-title":"EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines","volume":"65","author":"European Association of","year":"2014","journal-title":"European urology"},{"issue":"24","key":"26","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1002\/cncr.26172","article-title":"Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study","volume":"117","author":"Roupret","year":"2011","journal-title":"Cancer"},{"issue":"13","key":"27","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","article-title":"Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma","volume":"116","author":"Siefker-Radtke","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Bellmunt","year":"2014","journal-title":"European urology"},{"issue":"6","key":"29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.eururo.2011.12.010","article-title":"Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer","volume":"61","author":"Nordic Urothelial Cancer","year":"2012","journal-title":"European urology"},{"issue":"1","key":"30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012","volume":"112","author":"Delaney","year":"2014","journal-title":"Radiotherapy and oncology"},{"issue":"5","key":"31","first-page":"738","article-title":"Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study","volume":"35","author":"Mirimanoff","year":"1999","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"3 Pt 1","key":"32","first-page":"703","article-title":"Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy","volume":"160","author":"Sagalowsky","year":"1998","journal-title":"The Journal of urology"},{"issue":"27","key":"33","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"and Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Coltman","year":"1999","journal-title":"The New England journal of medicine"},{"issue":"3","key":"34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000350508","article-title":"Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis","volume":"91","author":"Zhou","year":"2013","journal-title":"Urologia internationalis"},{"issue":"11","key":"35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial","volume":"31","author":"Ikeda","year":"2013","journal-title":"Journal of clinical oncology"},{"issue":"11","key":"36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S1470-2045(13)70388-7","article-title":"Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis","volume":"14","author":"Tu","year":"2013","journal-title":"The Lancet Oncology"},{"issue":"1","key":"37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000092930","article-title":"Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract","volume":"77","author":"Hong","year":"2006","journal-title":"Urologia internationalis"},{"issue":"5","key":"38","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.juro.2010.06.106","article-title":"Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study","volume":"184","author":"Karakiewicz","year":"2010","journal-title":"The Journal of urology"},{"issue":"5","key":"39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00345-011-0775-z","article-title":"The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study","volume":"30","author":"Tsujimura","year":"2012","journal-title":"World journal of urology"},{"issue":"6","key":"40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/bju.12369","article-title":"Predictors of survival in patients with disease recurrence after radical nephroureterectomy","volume":"113","author":"Raman","year":"2014","journal-title":"BJU international"},{"issue":"1","key":"41","first-page":"e49","article-title":"High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy","volume":"32","author":"Kutikov","year":"2014","journal-title":"Urologic oncology"},{"issue":"8","key":"42","doi-asserted-by":"crossref","first-page":"686","DOI":"10.7150\/jca.7326","article-title":"The efficacy of adjuvant chemotherapy for locally advanced upper tract urothelial cell carcinoma","volume":"4","author":"Rhew","year":"2013","journal-title":"Journal of Cancer"},{"issue":"Suppl","key":"43","first-page":"S29","article-title":"Adjuvant chemotherapy for uroepithelial transitional cell carcinoma","volume":"20","author":"Nishiura","year":"1987","journal-title":"Cancer chemotherapy and pharmacology"},{"issue":"4","key":"44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0360-3016(92)90723-U","article-title":"Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter","volume":"24","author":"Reymond","year":"1992","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"7","key":"45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1442-2042.2004.00841.x","article-title":"Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer","volume":"11","author":"Koyanagi","year":"2004","journal-title":"International journal of urology"},{"issue":"1","key":"46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","article-title":"Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract","volume":"68","author":"Ku","year":"2006","journal-title":"Urology"},{"issue":"9","key":"47","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","article-title":"Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma","volume":"15","author":"Sugimura","year":"2008","journal-title":"International journal of urology"},{"issue":"3","key":"48","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration","volume":"182","author":"Kikuchi","year":"2009","journal-title":"The Journal of urology"},{"issue":"3","key":"49","first-page":"247","article-title":"Adjuvant and salvage radiotherapy for urothelial cell carcinoma of the upper urinary tract: experience in a single institution","volume":"35","author":"Hong","year":"2012","journal-title":"Chang Gung medical journal"},{"issue":"12","key":"50","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/jjco\/hys166","article-title":"A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"42","author":"Tsukamoto","year":"2012","journal-title":"Japanese journal of clinical oncology"},{"issue":"6","key":"51","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0090-4295(99)80346-X","article-title":"Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure","volume":"46","author":"Raymond","year":"1995","journal-title":"Urology"},{"issue":"5","key":"52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1442-2042.2001.00286.x","article-title":"Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study","volume":"8","author":"Yamashita","year":"2001","journal-title":"International journal of urology"},{"issue":"4","key":"53","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.juro.2014.10.022","article-title":"Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience","volume":"193","author":"Kanao","year":"2015","journal-title":"The Journal of urology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T21:12:34Z","timestamp":1749589954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,24]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1,10]]}},"alternative-id":["12239","27683040"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12239","relation":{},"ISSN":["1949-2553"],"issn-type":[{"type":"electronic","value":"1949-2553"}],"subject":[],"published":{"date-parts":[[2016,9,24]]}}}